JS
Insider
J Matthew Singleton
DirectorJ Matthew Singleton (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $1.3M of VKTX (16,000 sh × $79.50, as filed), executed Oct 25 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Oct 25 2024
Filed Oct 25 2024
Median ADV $77.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
VKTXRecent filings
VKTXSALE
Viking Therapeutics, Inc.
View filing →
$1.3M16,000 sh × $79.50
Exec Oct 25 2024
Filed Oct 25 2024 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. View filing → $716K
10,300 sh × $69.50
Exec Sep 20 2024
Filed Sep 20 2024 · 5:30 PM ET